Chronic Obstructive Pulmonary Disease (COPD) Treatment Market to reach USD 30.4 billion by 2031, expanding at a CAGR of 4.4%: TMR Report Wilmington, Delaware, United States, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The global chronic obstructive pulmonary disease (COPD) treatment market is projected to flourish at a CAGR of 4.4% from 2022...

Asthama And COPD Market Anticipated to Reach $49.1 Bn by 2030, Says Coherent Market Insights (CMI) Burlingame, July 25, 2023 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, “Asthma And COPD Market, By Drug Type (Bronchodilators (Short Acting Bronchodilators, Long Acting...

Genetic Chronic Obstructive Pulmonary Disease (COPD) Market to Surpass US$ 720.5 Million by 2030, Says Coherent Market Insights (CMI) Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global genetic chronic obstructive pulmonary disease (COPD) market is estimated to be valued at US$ 560.3...

At 6.4% CAGR, Global Nasal Cannula Market to Surpass US$ 10,491.1 Million by 2028, Says Coherent Market Insights (CMI) SEATTLE, Dec. 22, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global nasal cannula market is estimated to be valued at US$ 6,801.7 million in 2021 and is expected to exhibit...